Status:
RECRUITING
Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
Lead Sponsor:
University Health Network, Toronto
Conditions:
Suspected Sarcoidosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for path...
Detailed Description
This study is a prospective randomized control trial. More than 370 lymph nodes from approximately 128 patients with enlarged mediastinal and/or hilar lymph nodes (≥10 mm short-axis diameter on CT sca...
Eligibility Criteria
Inclusion
- -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
- (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
- history, physical exam, and other investigations, and booked for EBUS-TBNA.
Exclusion
- -Patients that are unable to provide informed consent
- \- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on
- clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,
- infection).
Key Trial Info
Start Date :
August 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06220526
Start Date
August 18 2023
End Date
February 28 2026
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 1L7